RetiPharma secures funding to prepare RP-001 for proof-of-concept study in retinal detachment Nov. 13, 2018 No Comments
New phase III trial investigates emixustat in macular atrophy secondary to Stargardt disease Nov. 12, 2018 No Comments
Clearside Biomedical discontinues Xipere combination therapy for RVO based on SAPPHIRE data Nov. 6, 2018 No Comments
Genetic variants in CD274 increase risk of Fuchs endothelial corneal dystrophy in smokers Oct. 31, 2018 No Comments
Clearside Biomedical presents additional phase III data for Xipere in uveitic macular edema Oct. 30, 2018 No Comments
RSS